Pay in 4 interest-free payments of $5.95 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
Micheroli R, Tellenbach C, Scherer A et al (2020) Effectiveness of secukinumab versus an alternative TNF inhibitor in patients with axial spondyloarthritis previously exposed to TNF inhibitors in the swiss clinical quality management cohort
Duration of treatment varies based on condition severity and individual response
In studies, patients with obesity or overweight conditions have experienced an average weight loss ranging from 10% to 15% of their initial body weight over a period of several months
This injection may provide sufficient pain relief to allow a patient to progress with a rehabilitative physical therapy program
US$ 22.09
US$ 23.31
US$ 20.33
